Oslo - Delayed Quote NOK

Hofseth BioCare ASA (HBC.OL)

1.3900 0.0000 (0.00%)
As of 9:36:51 AM GMT+2. Market Open.
Chart Range Bar
Loading chart for HBC.OL
  • Previous Close 1.3900
  • Open 1.3950
  • Bid 1.2550 x 800000
  • Ask 1.3850 x 619400
  • Day's Range 1.3900 - 1.3950
  • 52 Week Range 1.1000 - 2.4200
  • Volume 7,717
  • Avg. Volume 150,283
  • Market Cap (intraday) 703.66M
  • Beta (5Y Monthly) 0.26
  • PE Ratio (TTM) --
  • EPS (TTM) -0.3400
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Hofseth BioCare ASA produces and sells health nutritional products for humans and pets in Norway, the United Kingdom, France, Belgium, Italy, Germany, Turkey, rest of Europe, Japan, Asia, and the United States. The company offers ProGo, a bioactive peptide for weight management and metabolic health; OmeGo, a fish oil that provides a full spectrum of fatty acids and omegas; CalGo and NT-II, which are calcium collagen complexes that support joint and bone health; CollaGo; and PetGo, a non-soluble protein. Hofseth BioCare ASA was founded in 2000 and is headquartered in Ã…lesund, Norway.

www.hofsethbiocare.com

78

Full Time Employees

December 31

Fiscal Year Ends

Performance Overview

Trailing total returns as of 9/1/2026, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .

YTD Return

HBC.OL
5.30%
MSCI WORLD (^990100-USD-STRD)
11.99%

1-Year Return

HBC.OL
20.34%
MSCI WORLD (^990100-USD-STRD)
0.00%

3-Year Return

HBC.OL
56.56%
MSCI WORLD (^990100-USD-STRD)
65.96%

5-Year Return

HBC.OL
80.96%
MSCI WORLD (^990100-USD-STRD)
57.42%

Statistics

View More

Valuation Measures

Annual
As of 8/27/2026
  • Market Cap

    683.41M

  • Enterprise Value

    914.03M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.33

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    3.77

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -56.38%

  • Return on Assets (ttm)

    -17.57%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    242.2M

  • Net Income Avi to Common (ttm)

    -136.55M

  • Diluted EPS (ttm)

    -0.3400

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    107.98M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -54.74M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

People Also Watch